NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study ...

Review the side-effects of Calcitriol as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Details concerning the Calcitriol + Calcium + Vitamin K2 7 combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ...

Calcitriol 1mcg/mL; soln for IV inj. ≥13yrs: Initially 1–2mcg (0.02mcg/kg) 3 times weekly (approx. every other day); usual range: 0.5–4mcg 3 times weekly. May increase by 0.5–1mcg at 2–4 week ...

Although angiotensin-converting-enzyme inhibitors and angiotensin-receptor blockers can slow deterioration of renal function in patients with IgA nephropathy, these drugs do not address the ...

IV calcitriol treatment in patients with early-stage secondary hyperparathyroidism prevents parathyroid (PT) gland growth, researchers report. Masatomo Taniguchi, MD, of the Graduate School of Medical ...

This study evaluated the health-economic consequences of use of intravenous paricalcitol (Zemplar ®), oral calcitriol or oral and intravenous alfacalcidol for the treatment of patients with secondary ...

In patients with chronic heart failure, the vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D), also called calcitriol, and its ratio to parathyroid hormone (PTH 1-84) may help predict ...

Elevated calcium and phosphorus levels after therapy with injectable vitamin D for secondary hyperparathyroidism may accelerate vascular disease and hasten death in patients undergoing long-term ...

HOXB13-to-IL17BR Expression Ratio Is Related With Tumor Aggressiveness and Response to Tamoxifen of Recurrent Breast Cancer: A Retrospective Study This study suggests that DN-101 treatment was ...

A decision analysis model focusing on hospitalisation, survival rates and utilities for paricalcitol and calcitriol was used (Figure 1). Costs included yearly cost for medications and the costs ...